Skip to main content
Clinical Trials/NCT05012527
NCT05012527
Completed
Not Applicable

Retrospective Review of Gastrointestinal System Endoscopy Procedures

Istanbul Sultanbeyli State Hospital1 site in 1 country15,448 target enrollmentJune 11, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Endoscopy
Sponsor
Istanbul Sultanbeyli State Hospital
Enrollment
15448
Locations
1
Primary Endpoint
Polyp/tumor detection rate of symptomatic patients' endoscopy
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The aim of the study is retrospectively evaluating all features of endoscopic and pathological diagnoses of cases who underwent upper and lower gastrointestinal endoscopy.

Detailed Description

Gastrointestinal system endoscopy has an important place in the diagnosis and treatment of many diseases related to this system and provides an alternative to current surgical methods with its ever-expanding field of application. Upper and lower gastrointestinal endoscopy procedures are performed with many indications, such as new complaints in the gastrointestinal tract at the age of 50 and over, family history of gastrointestinal malignancy. In addition, the importance of endoscopy is gradually increasing as tissue and cell samples can be taken for histopathological studies and endoscopic treatment of some diseases. The aim of the study is to review patients' indications, distribution by age and gender, frequency of lesions diagnosed on endoscopy, prevalence, size, histology and location of polyps detected and excised, results of endoscopic and pathological diagnoses. The study population consists of the patients who were examined at the Istanbul Sultanbeyli State Hospital Endoscopy Unit between 01.01.2016 and 01.01.2021. The patients' data will be scanned retrospectively by accessing their files from the computer database.

Registry
clinicaltrials.gov
Start Date
June 11, 2021
End Date
October 1, 2021
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Istanbul Sultanbeyli State Hospital
Responsible Party
Principal Investigator
Principal Investigator

Muhammer Ergenç, MD

General Surgeon

Istanbul Sultanbeyli State Hospital

Eligibility Criteria

Inclusion Criteria

  • Adult patients (over 18 years old)
  • Patients who have undergone the procedure in our endoscopy unit

Exclusion Criteria

  • Under 18 years old
  • Patients whose information cannot be accessed in the system records.

Outcomes

Primary Outcomes

Polyp/tumor detection rate of symptomatic patients' endoscopy

Time Frame: During 3 months (retrospective endoscopy data review)

The patients with polyp / the total number of symptomatic patients endoscopy The patients with tumor / the total number of symptomatic patients endoscopy

Non-neoplastic biopsy results

Time Frame: During 3 months (retrospective endoscopy data review)

The patients with non-neoplastic biopsy results / the total patients

Prevalence of gastric/bowel diseases in histopathology

Time Frame: During 3 months (retrospective endoscopy data review)

The patients with gastric disease / the total patients The patients with bowel disease / the total patients

Polyps localization and frequency

Time Frame: During 3 months (retrospective endoscopy data review)

The patients with polyp / the total patients Number of polyp localizations, Type (Rectum, Sigmoid colon, Descending colon, Splenic flexure, Transverse colon, Hepatic flexure, Ascending colon, Caecum, Multiple localization)

Type of endoscopy

Time Frame: During 3 months (retrospective endoscopy data review)

Number of each endoscopy, Type (esophagogastroduodenoscopy, colonoscopy, rectosigmoidoscopy)

Indications

Time Frame: During 3 months (retrospective endoscopy data review)

Number of endoscopic indications, Type (Abnormal imaging, GI bleeding, Anemia, Screening and surveillance, Diarrhea, Constipation, Abdominal pain, Weight loss, Dyspepsia, Heartburn, Dysphagia, Odynophagia, Upper belly pain or chest pain that is not heart-related, Intractable vomiting, Bleeding in the upper, Persistent gastroesophageal reflux symptoms, Occult gastrointestinal bleeding, Other)

Age

Time Frame: During 3 months (retrospective endoscopy data review)

Age distribution of patients in endoscopic procedures and histopathological examinations

Gender

Time Frame: During 3 months (retrospective endoscopy data review)

Sex distribution of patients in endoscopic procedures and histopathological examinations

Procedure-related complications rates

Time Frame: During 3 months (retrospective endoscopy data review)

The patients with complications / the total patients Number of adverse events; early or late (within 1 month), related to the endoscopic procedure, Type (cardiopulmonary complication, gastrointestinal bleeding, perforation, mortality)

Polyp/tumor detection rate of screening endoscopy

Time Frame: During 3 months (retrospective endoscopy data review)

The patients with polyp / the total number of screening endoscopy patients The patients with tumor / the total number of screening endoscopy patients

Completeness rate of the procedures

Time Frame: During 3 months (retrospective endoscopy data review)

The number of completed procedures / total number of procedures

Prevalence of benign/malign gastrointestinal disease in the endoscopy

Time Frame: During 3 months (retrospective endoscopy data review)

The patients with benign gastrointestinal disease / the total patients The patients with malign gastrointestinal disease / the total patients

Prevalence of advanced neoplasia

Time Frame: During 3 months (retrospective endoscopy data review)

The patients with advanced neoplasia / the total patients

Prevalence of gastric/colorectal cancer

Time Frame: During 3 months (retrospective endoscopy data review)

The patients with gastric cancer / the total patients The patients with colorectal cancer / the total patients

Study Sites (1)

Loading locations...

Similar Trials